Fosun International LTD Lexicon Pharmaceuticals, Inc. Transaction History

Fosun International LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$1.2 - $6.66 $217,200 - $1.21 Million	-181,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$4.36 - $7.94 $350,452 - $638,209	80,379 Added 79.88%	181,000 $952,000
Q4 2018 Jan 31, 2019	BUY	$6.15 - $10.51 $618,819 - $1.06 Million	100,621 New	100,621 $639,000

140

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $130M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.